Your browser doesn't support javascript.
loading
CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.
Teh, Yoong Mond; Lim, Soo Kun; Jusoh, Norhana; Osman, Kahar; Mualif, Siti Aisyah.
Afiliação
  • Teh YM; School of Biomedical Engineering and Health Sciences, Faculty of Engineering, Universiti Teknologi Malaysia (UTM), Johor Bahru, Malaysia.
  • Lim SK; Renal Division, Department of Medicine, Faculty of Medicine, University of Malaya (UM), Kuala Lumpur, Malaysia.
  • Jusoh N; School of Biomedical Engineering and Health Sciences, Faculty of Engineering, Universiti Teknologi Malaysia (UTM), Johor Bahru, Malaysia.
  • Osman K; Medical Device and Technology Centre (MEDiTEC), Universiti Teknologi Malaysia, Malaysia.
  • Mualif SA; School of Biomedical Engineering and Health Sciences, Faculty of Engineering, Universiti Teknologi Malaysia (UTM), Johor Bahru, Malaysia.
Biomed Res Int ; 2021: 6671552, 2021.
Article em En | MEDLINE | ID: mdl-33506028

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Antígeno B7-1 / Nefropatias / Nefrose Lipoide Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Malásia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Antígeno B7-1 / Nefropatias / Nefrose Lipoide Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Malásia
...